|Articles|September 20, 2011

Positive Phase II study results announced

Novagali Pharma has announced positive results from its Phase II trial of the preservative-free cationic emulsion, Catioprost.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.


Latest CME